10-K: Centrus Energy Corp. Details Share Structure and Operational Progress in Annual Filing

Centrus Energy Corp.'s annual filing outlines its capital structure, ongoing HALEU production, and strategic positioning in the nuclear fuel market.

Summary

• Centrus Energy Corp.'s annual filing details its authorized capital stock, consisting of 100 million common shares and 20 million preferred shares.
• The company's Class A Common Stock is registered and trades on the NYSE American under the symbol LEU.
• Centrus operates two segments: LEU, which supplies nuclear fuel components, and Technical Solutions, focused on advanced engineering and HALEU production.
• The LEU segment accounts for 84% of the company's revenue, primarily from sales of enriched uranium to utilities.
• The Technical Solutions segment is focused on restoring domestic uranium enrichment capabilities and producing HALEU for advanced reactors.
• Centrus began HALEU enrichment operations at its Piketon, Ohio facility in October 2023 under a contract with the DOE.
• The company's LEU order book extends to 2030 and is valued at approximately $1.0 billion as of December 31, 2023.
• Centrus's largest SWU supplier is TENEX, with a contract extending through 2028, followed by Orano.
• The company is exploring the opportunity to deploy LEU enrichment alongside HALEU enrichment to meet a range of commercial and U.S. government requirements.
• The company is also exploring strategic partnerships for technologies complementary to HALEU production, including deconversion and fuel fabrication.

Sentiment

Score: 6

Explanation: The document presents a mixed sentiment. While there are positive developments such as the start of HALEU production and a strong order book, there are also significant risks and challenges, including supply chain issues, competition, and dependence on government funding. The delay in HALEU production is a negative factor.

Positives

• Centrus has a diverse supply base for LEU, including long-term contracts and spot purchases.
• The company is well-positioned to benefit from the growing demand for HALEU in the advanced reactor market.
• Centrus is exploring opportunities to expand its business beyond uranium enrichment, offering new services in complementary markets.
• The company has a strong focus on safety, security, and ethical business practices.
• The company has a diverse base of supply that includes existing inventory of LEU, long-term contracts with enrichment producers, purchases and loans from secondary sources, and spot purchases of SWU, uranium, and LEU.

Negatives

• The company faces significant competition from major LEU producers, many of which are government-owned.
• The company is dependent on a few large customers and suppliers, which could adversely affect its business.
• The company is exposed to price volatility in the uranium and enrichment markets.
• The company has significant long-term liabilities, including debt and pension obligations.
• The company is dependent on intercompany support from Enrichment Corp.

Risks

• The war in Ukraine and related sanctions could disrupt the company's supply chain and ability to import Russian LEU.
• The company's ability to operate the HALEU enrichment facility after the current contract depends on securing additional funding and contracts.
• The company faces risks related to cost overruns on fixed-price and cost-share contracts.
• The company's ability to utilize its NOL carryforwards may be limited.
• The company is subject to government regulation and policies, including by the NRC and the DOE.
• The company's operations involve the use, transportation, and disposal of hazardous materials, which could result in liability.
• The company is subject to cybersecurity risks that could impact its business operations.
• The company is dependent on continued U.S. government funding and government appropriations, which may not be made on a timely basis or at all.

Future Outlook

Centrus is exploring the opportunity to deploy LEU enrichment alongside HALEU enrichment to meet a range of commercial and U.S. government requirements. The company expects to submit bids for both RFPs issued by the DOE, with the goal of expanding HALEU production capability at the Piketon facility and building a deconversion facility, subject to, among other things, availability of funding and/or offtake commitments.

Management Comments

• Centrus is pioneering U.S. production of HALEU, enabling the deployment of a new generation of HALEU-fueled reactors to meet the worlds growing need for carbon-free power.
• Centrus is exploring the opportunity to deploy LEU enrichment alongside HALEU enrichment to meet a range of commercial and U.S. government requirements, which could bring operational synergies while increasing sales opportunities.
• Our goal is to deliver major components of the next-generation nuclear fuels that will power the future of nuclear energy as it provides reliable carbon-free power around the world.

Industry Context

The document highlights the increasing demand for nuclear energy as a reliable source of carbon-free power, particularly with the development of advanced reactors that require HALEU. The war in Ukraine has also contributed to a significant increase in market prices for enrichment and prompted calls for public and private investment in new, domestic uranium enrichment capacity.

Comparison to Industry Standards

• Centrus's global market share of enrichment for the LEU market is less than 5%, indicating it is a smaller player compared to major suppliers like Rosatom/TENEX, Urenco, CNEIC, and Orano.
• The document notes that Rosatom/TENEX has a production capacity of approximately 27 million SWU per year, Urenco has approximately 18 million SWU per year, CNEIC has approximately 9 million SWU per year, and Orano has approximately 8 million SWU per year, highlighting the scale of Centrus's competitors.
• Centrus is the only company with a license from the NRC actively enriching up to 20% U 235 assay HALEU and that is operating a small scaled HALEU production facility, which positions it uniquely in the HALEU market.
• The document mentions that the United States has not had domestic uranium enrichment capability suitable to meet U.S. national security requirements since the Paducah GDP shut down in 2013, emphasizing the importance of Centrus's efforts to restore this capability.

Management Changes

Legal Proceedings

• Centrus and Enrichment Corp. are defendants in lawsuits alleging damages resulting from releases at the former Portsmouth GDP and the centrifuge facilities near Piketon.
• The company is involved in various pending legal proceedings and claims that arise in the ordinary course of business.

Related Party Transactions

• Mr. Williams, Chairman of the Centrus Board of Directors, also served on the board of B. Riley Financial, Inc., which is a party to the Companys At Market Sales Agreement.

Stakeholder Impact

• Shareholders: The company's financial performance and strategic decisions will directly impact shareholder value.
• Employees: The company's ability to attract and retain key personnel is critical to its success.
• Customers: The company's ability to deliver LEU and HALEU on time and at competitive prices is important to its customers.
• Suppliers: The company's relationships with its suppliers are critical to its ability to operate.
• Creditors: The company's ability to meet its debt obligations is important to its creditors.

Next Steps

• Centrus expects to submit bids for the DOE's RFPs focusing on deconversion and production of HALEU.
• The company will continue to explore opportunities to deploy LEU enrichment alongside HALEU enrichment.
• Centrus will continue to monitor the situation closely and assess the potential impact of any new sanctions and how the impact on the Company might be mitigated.
• The company will continue to evaluate opportunities to grow its business organically or through acquisitions and other strategic transactions.

Key Dates

Keywords

HALEU, LEU, uranium enrichment, nuclear fuel, TENEX, Orano, American Centrifuge, DOE, nuclear reactors, SWU